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LEITERS 10 THE EDITOR
pry
The comments and dramatic angioscopic images of a coronary
stenosis after inlrauperaliac cxcimer ascr angioplasly are greatly
appreciated : however . the obscrvatien+of Diethrich el all need to be
discussed in relation to current cxcimer luser angioplasty equipment
and techniques .
First, the prototype catheter used by them was abandoned over
a year ago when more flexible 109 pm fiber optics replaced the stiffer
200 pct fiber optics. Marc recently, laser catheters with neon more
flexible 50 Amt fiber optics have beer, developed and are currently in
clinical use
. Secondly, in the percutaneous application of these
devices . the catheters arc
routinely
advanced over firmer 0.018 in .
(0
.036 cm) guide wires under fluoroscopic guidance in order to
provide more support and to maintain coaxial position, It is not clear
from their repon whether the laser catheter was advanced over a
guide wire-a technique that would be difficult to perform intmop-
eratively as compared with a procedure performed with Onoroseopy
and angiography in a calheterization laboratory . In addition • an
energy fluence of 40 mJ/mm e and a repetition rate of only 10 Hz arc
less than the recommended operating variables fat this particular
device of 50
to to ni/mutt and 25 iiz .
FO ,a1 : y , a. pathat'Smci,important.operatortechniqueisakey
factor in performing excimer laser angioplasty safely Like me .
Diethrich and coworkers have considerable experience with laser
thermal angioplasty in which continuous motion of a heated metal
probe is required to avoid excessive thermal damage and adherence
to the vessel wall . Initial experimental and clinical (I) studies of
excimer laser angioplasty have found that such rapid motion is not
only unnecessary but rather is contraindicated . Specifically, a slow
advancement of the catheter through a stenosis at a rate of 0 .5 to
I minis is important in decreasing the incidence of dissection on
angiography . For one experienced in laser thermal angioplasty, the
technique of excimer laser angioplasty actually requires consider-
able restraint to present mechanical dissection with the laser cath .
eter . Ac the details of the techninue used by Diethrich e
t al. are not
described . i t is possible that rapid advancement of a rigid catheter
through a lesion with inadequate guidseec and coaxial support as
well as ineffective laser parameters could easily have caused me-
chanical dissection unrelated to the use of a laser
.
Thus. I share the authors' concern about overenthusiasm for
excimer laser angioplasty and agree [hat the laser catheters require
significant modifications. In addition, use of appropriate laser pa•
sufferers and careful technique will be required to property evaluate
the role of this new technology in the treatment of coronary artery
disease
.
TIMOTHY A. SANBORN . M
D
Cevlioinep Diriviin
Depnrtn,em of Slrdvive
Siam Sinai .5rerlhni t 'vin,
Gunner Let. Peer
New fork . Sex fad 10029
Reference
t . lenburn TA . Tone SR . Shame SK, tt at . Penmanaeue coroner, esiunnr laser
nod henna v,a,vnlaso: inAal ehmcol eau yaemaense,np~va,,rh ~ r«w, . o 10
patients
.I Am Call Cudel INS 17 se_q
Correction
There is a reversal in meaning in the concluding two sentences of my
editorial, "Exercise Intolerance in Heart Failure." which appeared
in the April issue IJ Am Coll Cordial 1991
:17407-1-41
.
The last three sentences of the
last
paragraph
should read :
"Thus, the exercise limitation in patients classified as having
systolic or diastolic dysfunction ii related to a relative failure of the
Starling meehaoism- The impudence of the study of Kiteman et al
(8) is to illustrate an eslreme form of this phenomenon in patients in
whom a marked decrease in left ventricular compliance results in a
flat diastolic pressure-volume response curve . Their finding may
have important implications fur those seeking effective therapeutic
agents to reduce or prevent the decrease in compliance associated
with lob vcntrieatne hypertrophy in hypertension, hypertrephie
cardiornyapethy and ischemic heart muscle disease ."
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Cardiac-Specific Antibodies in Dilated
Cardiohnyopathy
Caforio et al . (1) reported the detection, of organ-specific cardiac
antibodies in patients with dilated cardiomyopathy with much
greater frequency than in patients with other cardiac diseases and
normal control subjects, and state that their detection provides a
novel serologic marker of eutoimmunity in this condition . We would
like to stake the following points-
I . These antibodies were vemnwn in the patients with fewer
symptoms and those with a disease duration of t2 years. The
authors speculate that the presence of autihody in only 26% of
patients with diluted cardiomyopethy could be due
to reduction in
antibody levels with disease progression but do not state the
duration of symptoms in each patient or the frequency of organ-
specific cardiac antibody in those with the shortest histories (i-ei
e6 months),
2 . Genetic factors are important in determining immune re-
sponse: the ethnic origin of the study population is not mentioned so
we do not know whether these findings are universally applicable .
3 . Were virology studies performed and cardiac biopsy speci-
men
lakes'
It would be interesting to compare the biopsy findings in
those with organ-specific cardiac antibody to those without in regard
to evidence of myocarditis .
4 . The authors mention mitochondria) antigens (including ade-
nine nucleotide translucalor and the M7 antigen) as being potential
auto-antigens but mitochondrial auto-antigens are usually nut organ
specific
(2)
. In addition, cardiac-specific anti-myosin isoform anti-
bodies produce a striated staining protein on indirect immnnofluo-
rescene in mice (J) . not diffuse cytoplasmic staining . These antigens
are therefore unlikely to be involved,
Cip: .n,ating antimyolemmal antibodies have been detected in
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approximately 30'G of patient, wiIh
,hr-
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141 . We studied seven patients with dilated cardiomyopathy 15) and
symptoms lot <6 rconths to estimate their incidence in more acute
cases. These antihodies, detected in vitro using nioct rat End human
cardiocytes and indirect immunvduureuence, were present in ,m
cases 186241 . The eytnlgtia in dec for the group wv, . 0 .51
..
11 m5
(normal range 092 - 007 . p < 0 .05) mdicztmm efee
. On cytdysls
.
Isolated vital carol from fresh retinal human heart was tired
in this and pievious studio (4). eliminating the pa ,sib lily of artifact
gene-Yted by incorrect sectioning of ti-e .
We question whether cardiac specahcny I, a rcquremenn of
antibody-mediated Immmlolugic damage, Cruss-reas(tse anumvo-
lemmal antibodies are only cytolytic for cardiac myorytLI and there
is considerable evidence to suggest that the) are eticparh*ECmc in
postmyocarditic dilated cardiomyopathy I=hl
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